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tion of technology to the experimental problem at hand, change in pAPCs or cells exposed to cytokines that
since it is difficult to imagine approaching the question enhance antigen presentation? Do immunoproteasomes
in any other way. produce shorter peptides less dependent on TPP II
Extending their prior findings on aminopeptidase cleavage? Or do PA28 proteasome regulators, whose
cleavage of peptides in living cells (Reits et al., 2003), role in antigen presentation has remained elusive, play
Reits et al. show that as peptides exceed 15 residues this role? Does TPP II also participate in the generation
the critical role of aminopeptidases in degradation is of peptides from exogenous antigens? If so, does it
usurped by TPP II. TPP II functions as both an aminopep- colocalize with proteasomes and TAP in regions where
tidase and an endopeptidase. Curiously, its endopepti- phagosomes fuse with the ER in pAPCs? And finally the
dase activity requires an unblocked amino terminus, big one: have all of the major proteases involved in the
suggesting that the two activities are linked. The judi- generation of class I peptide ligand been identified, or
cious insertion of D amino acids (which resist proteolytic do other surprises await us?
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of the TCR/CD3 complex, they share properties withBetting on NKT and NK Cells
“innate lymphocytes” that closely resemble NK cells,
such as the expression of invariant, germline-encoded
receptors (Bendelac et al., 2001). Although the definition
of NKT cells is expanding (Kronenberg and Gapin, 2002),Natural killer T (NKT) cells, as their name implies, consti-
a specific TCR chain (V14/J28) is expressed by mosttutively express markers and receptors first identified on
murine NKT cells and is strikingly conserved betweenbona fide natural killer (NK) cells, supporting a potential
mice and humans. These V14-invariant (V14i) NKTrelationship between NKT and NK cells. In this issue of
Immunity, Townsend et al. further define this relationship cells recognize CD1-restricted antigens, as represented
in terms of the transcription factor, T-bet. by the marine sponge-derived glycolipid, -galactosyl
ceramide (-GalCer). Perhaps the best known function
of NKT cells is related to their unique innate capacityAlthough NKT cells display rearranged T cell antigen
to secrete several cytokines, including IL-4 and inter-receptor (TCR) chains in association with the CD3 com-
plex in distinction from NK cells that lack expression feron- (IFN), very quickly after TCR stimulation in vivo.
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NKT cells play roles in immune responses ranging from of a related transcription factor, Eomesodermin, in NK
but not NKT cells, in a manner reminiscent of a recentlyanti-pathogen effects, due to recognition of glycolipids
presented by CD1, to the pathogenesis of inflammatory reported role of Eomesodermin in CD8 T cell effector
function (Pearce et al., 2003). Nevertheless, T-bet defi-conditions, such as allergic asthma.
Similar to conventional T cells, NKT cells fail to devel- ciency affects the development of both NKT and NK
cells.op in mice with deficiencies in the recombinase machin-
ery for antigen receptor gene rearrangement or in the In prior studies of NKT or NK cell defects in transcrip-
tion factor-deficient mice, it was not always clear if theabsence of the restricting MHC element. By contrast,
NKT cells also fail to develop in mice lacking lympho- transcription factor defects were cell intrinsic (autono-
mous) or extrinsic (micro-environment). Such effects aretoxin- (Lt) or components of the IL-15 pathway, such
as IL-15 and IL-15R, and IL-2/15R, whereas conven- often revealed when transcription factor-deficient he-
matopoietic stem cells are transplanted into wild-typetional T cell development is grossly intact (Kronenberg
and Gapin, 2002). Such data support the thesis that NKT recipients and vice versa with an allotypic marker, such
as Ly5.1, to detect donor-derived mature cells in thecells form a distinct sublineage of T cells, differing in
terms of developmental requirements. bone marrow chimeras. By using the chimera approach,
Townsend et al. demonstrate that the T-bet deficiencyLike NKT cells, NK cells express immunoreceptor ty-
rosine-based activation motif (ITAM)-containing signal- on NKT and NK cell development is a stem cell intrinsic
effect (Townsend et al., 2004). They then go one steping chains coupled to target recognition receptors that
are germline encoded (though unrearranged). In C57BL/6 further and demonstrate that restoration of T-bet ex-
pression by retroviral transduction of T-bet-deficientmice, these receptors include the lectin-like NK1.1
(Nkrp1c) molecule and several others encoded in the thymocytes or hematopoietic stem cells reconstitutes
NKT and NK cell development, respectively. Thus, theNK gene complex. In addition to target killing, NK cells
are poised for prompt cytokine release in response to T-bet deficiency is one of only a few clearly documented
examples of cell intrinsic transcription factor defectsinflammation and infection, akin to NKT cell responses.
Indeed, there is evidence indicating crosstalk between that affect development of both NKT and NK cells since
others have either not been documented (Ets-1), areNKT and NK cells during acute inflammatory responses
(Bendelac et al., 2001), and the shared receptors may extrinsic (IRF-1, RelB), or have more widespread devel-
opmental deficits (Ikaros, PU.1, MEF, IRF-2, RelB,contribute to the immediate responses of these cells.
Interestingly, Lt and IL-15 pathway targeted mutant GATA-3) (Colucci et al., 2003).
An intrinsic defect with effects on NKT and NK cellsmice lacking NKT cells also lack NK cells, indicating that
NKT and NK cells require some of the same cytokines suggests that the pathways for final differentiation of
NKT and NK cells could be similar but operate in alreadyfor functional development and highlighting the close
developmental relationship of NKT and NK cells. Also, committed immature cells, as Townsend et al. favor.
Alternatively, T-bet could operate at the level of a precur-both NKT and NK cells are absent in mice deficient in
certain transcription factors, such as Ets-1 and IRF-1, sor cell that gives rise to either NKT or NK cell but not
other lineages. Moreover, it remains possible that theand their absence is relatively selective with few effects
on conventional T cell development. Thus, there is a precise function of T-bet may differ in different lineage
contexts. Finally, T-bet may have other cell intrinsic rolesclose developmental relationship between NKT and
NK cells. in the development or terminal differentiation of other
immune cells. These topics are worthy of further evalu-Townsend et al. provide a very comprehensive evalua-
tion of NKT and NK cell development in mice deficient ation.
Of course, a cell intrinsic defect in T-bet-deficientin T-bet (T-box expressed in T cells), a transcription
factor first identified in terms of T helper cell differentia- animals should mean that T-bet is expressed in develop-
ing NKT and NK cells. Indeed, Townsend et al. confirmtion but now known to affect functions of other immune
cells (Townsend et al., 2004). T-bet-deficient mice have this and suggest its expression is related to the level of
cell maturation. For future studies, it would be of interesta marked reduction in NKT cell number in peripheral
tissues as detected by anti-NK1.1 and by -GalCer-CD1 to evaluate T-bet expression in developing NK cells at
different maturation stages that are just beginning totetramers. This reduction is apparently not due to an
effect of T-bet on CD1 expression. Detailed analyses be defined in the bone marrow (Colucci et al., 2003;
Yokoyama et al., 2004). Interestingly, T-bet transcriptsof the few remaining NKT cells in T-bet-deficient mice
indicate a block at an intermediate stage of NKT cell can be markedly upregulated (more than 10-fold) in ma-
ture NK cells by various cytokines, especially by IL-12development. In contrast to the effect of T-bet on NKT
numbers and to the profound effects of Ets-1 and IRF-1 plus IL-18, whereas more modest increases were noted
with stimulation of ITAM-coupled NK cell activation re-deficiency on NK cell development (Kronenberg and
Gapin, 2002), the effect of T-bet deficiency on NK cells ceptors. This observation suggests another role for
T-bet in regulating the final effector functions of NK cellsis more subtle, with only modest reductions in NK cell
numbers. Similar to the block in NKT cell development, in response to cytokines, rather than development per
se, perhaps more akin to T helper differentiation that ishowever, the T-bet-deficient NK cells manifest defects
in expression of markers associated with their final mat- also dependent on the cytokine milieu. If so, this possi-
bility suggests that the NK cell defect in T-bet deficiencyuration steps (Yokoyama et al., 2004) and abnormalities
in the effector functions of mature NK cells, such as could also be due to defective signaling and gene activa-
tion in response to inflammation rather than primarilycytokine production and to a less impressive extent,
cytotoxicity. Some of the less dramatic effects on NK due to arrested development of mature NK cells as
Townsend et al. favor. These two related aspects ofcells may be due to the T-bet-independent expression
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T-bet function in NK cells may prove difficult to study Moreover, the putative redundant role of Eomesodermin
in isolation unless T-bet affects transcription of only in NK cell development requires further analysis. Never-
selective genes, directly or indirectly. theless, immunologists now have significant new in-
What genes are directly affected by T-bet? Townsend sights in the dissection of the molecular basis of NKT
et al. provide novel insight with a modified chromatin and NK development and effector function, and these
immunoprecipitation experiment in which proteins are findings may also lead to clues in understanding autoim-
crosslinked to DNA, immunoprecipitated with anti-T-bet mune diseases.
antibody, and the target DNA identified by PCR. These
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presumably Townsend et al. did not find significant evi-
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